simpson neumann (IMAGE)
Caption
Co-author Spenser Simpson, PhD, and corresponding author Kiel Neumann, PhD, St. Jude Department of Radiology, radiolabeled an FDA-approved drug used to treat ALS and repurposed it to track oxidative stress, a key contributor to brain injury and neurodegenerative diseases, such as Alzheimer’s disease
Credit
St. Jude Children's Research Hospital
Usage Restrictions
none
License
Original content